DNase

DRUG3 trials

Sponsors

The Hospital for Sick Children, University of Illinois at Chicago, University of Florida

Conditions

Dry EyePleural DiseasesPleural Empyema

Phase 1

DNase Treatment for Dry Eyes

TerminatedNCT02193490

University of Illinois at ChicagoDry Eye

Start: 2014-07-31End: 2017-10-11Updated: 2020-01-18

Phase 3

Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

CompletedNCT01717742

The Hospital for Sick ChildrenPleural Empyema

Start: 2012-12-31End: 2017-12-31Updated: 2020-04-14

Phase 4

Fibrinolytic Therapy Versus Medical Thoracoscopy

CompletedNCT03213834

University of FloridaPleural Diseases

Start: 2017-09-14End: 2020-02-04Updated: 2024-02-20

Related Papers

Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema

JAMA Pediatrics2020-02-0334 citations

Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.

2017-06-2411 citations